Sanofi (France): Q3 2012 Business EPS(1) Reflects Patent Expirations

In order to facilitate an understanding of our operational performance, we comment on our business net income statement. Business net income^1 is a non-GAAP financial measure. The consolidated income statement for the 9 months of 2012 is provided in Appendix 7. A reconciliation of business net income to consolidated net income is provided in Appendix 6. Consolidated net income for the first 9 months of 2012 was €4,557 million, compared to €4,254 million for the first 9 months of 2011. Consolidated EPS for the first 9 months of 2012 was €3.45 versus €3.23 for the first 9 months of 2011.

MORE ON THIS TOPIC